Global Viral and Non-Viral Vector Manufacturing Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Viral and Non-Viral Vector Manufacturing Market Size 2017-2028

2.1.2 Viral and Non-Viral Vector Manufacturing Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Viral and Non-Viral Vector Manufacturing Segment by Type

2.2.1 Viral Vectors

2.2.2 Non-Viral Vectors

2.3 Viral and Non-Viral Vector Manufacturing Market Size by Type

2.3.1 Viral and Non-Viral Vector Manufacturing Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Viral and Non-Viral Vector Manufacturing Market Size Market Share by Type (2017-2022)

2.4 Viral and Non-Viral Vector Manufacturing Segment by Application

2.4.1 Gene Therapy

2.4.2 Vaccinology

2.4.3 Cell Therapy

2.4.4 Others

2.5 Viral and Non-Viral Vector Manufacturing Market Size by Application

2.5.1 Viral and Non-Viral Vector Manufacturing Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Viral and Non-Viral Vector Manufacturing Market Size Market Share by Application (2017-2022)

3 Viral and Non-Viral Vector Manufacturing Market Size by Player

3.1 Viral and Non-Viral Vector Manufacturing Market Size Market Share by Players

3.1.1 Global Viral and Non-Viral Vector Manufacturing Revenue by Players (2020-2022)

3.1.2 Global Viral and Non-Viral Vector Manufacturing Revenue Market Share by Players (2020-2022)

3.2 Global Viral and Non-Viral Vector Manufacturing Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Viral and Non-Viral Vector Manufacturing by Regions

4.1 Viral and Non-Viral Vector Manufacturing Market Size by Regions (2017-2022)

4.2 Americas Viral and Non-Viral Vector Manufacturing Market Size Growth (2017-2022)

4.3 APAC Viral and Non-Viral Vector Manufacturing Market Size Growth (2017-2022)

4.4 Europe Viral and Non-Viral Vector Manufacturing Market Size Growth (2017-2022)

4.5 Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size Growth (2017-2022)

5 Americas

5.1 Americas Viral and Non-Viral Vector Manufacturing Market Size by Country (2017-2022)

5.2 Americas Viral and Non-Viral Vector Manufacturing Market Size by Type (2017-2022)

5.3 Americas Viral and Non-Viral Vector Manufacturing Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Viral and Non-Viral Vector Manufacturing Market Size by Region (2017-2022)

6.2 APAC Viral and Non-Viral Vector Manufacturing Market Size by Type (2017-2022)

6.3 APAC Viral and Non-Viral Vector Manufacturing Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Viral and Non-Viral Vector Manufacturing by Country (2017-2022)

7.2 Europe Viral and Non-Viral Vector Manufacturing Market Size by Type (2017-2022)

7.3 Europe Viral and Non-Viral Vector Manufacturing Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Viral and Non-Viral Vector Manufacturing by Region (2017-2022)

8.2 Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size by Type (2017-2022)

8.3 Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Viral and Non-Viral Vector Manufacturing Market Forecast

10.1 Global Viral and Non-Viral Vector Manufacturing Forecast by Regions (2023-2028)

10.1.1 Global Viral and Non-Viral Vector Manufacturing Forecast by Regions (2023-2028)

10.1.2 Americas Viral and Non-Viral Vector Manufacturing Forecast

10.1.3 APAC Viral and Non-Viral Vector Manufacturing Forecast

10.1.4 Europe Viral and Non-Viral Vector Manufacturing Forecast

10.1.5 Middle East & Africa Viral and Non-Viral Vector Manufacturing Forecast

10.2 Americas Viral and Non-Viral Vector Manufacturing Forecast by Country (2023-2028)

10.2.1 United States Viral and Non-Viral Vector Manufacturing Market Forecast

10.2.2 Canada Viral and Non-Viral Vector Manufacturing Market Forecast

10.2.3 Mexico Viral and Non-Viral Vector Manufacturing Market Forecast

10.2.4 Brazil Viral and Non-Viral Vector Manufacturing Market Forecast

10.3 APAC Viral and Non-Viral Vector Manufacturing Forecast by Region (2023-2028)

10.3.1 China Viral and Non-Viral Vector Manufacturing Market Forecast

10.3.2 Japan Viral and Non-Viral Vector Manufacturing Market Forecast

10.3.3 Korea Viral and Non-Viral Vector Manufacturing Market Forecast

10.3.4 Southeast Asia Viral and Non-Viral Vector Manufacturing Market Forecast

10.3.5 India Viral and Non-Viral Vector Manufacturing Market Forecast

10.3.6 Australia Viral and Non-Viral Vector Manufacturing Market Forecast

10.4 Europe Viral and Non-Viral Vector Manufacturing Forecast by Country (2023-2028)

10.4.1 Germany Viral and Non-Viral Vector Manufacturing Market Forecast

10.4.2 France Viral and Non-Viral Vector Manufacturing Market Forecast

10.4.3 UK Viral and Non-Viral Vector Manufacturing Market Forecast

10.4.4 Italy Viral and Non-Viral Vector Manufacturing Market Forecast

10.4.5 Russia Viral and Non-Viral Vector Manufacturing Market Forecast

10.5 Middle East & Africa Viral and Non-Viral Vector Manufacturing Forecast by Region (2023-2028)

10.5.1 Egypt Viral and Non-Viral Vector Manufacturing Market Forecast

10.5.2 South Africa Viral and Non-Viral Vector Manufacturing Market Forecast

10.5.3 Israel Viral and Non-Viral Vector Manufacturing Market Forecast

10.5.4 Turkey Viral and Non-Viral Vector Manufacturing Market Forecast

10.5.5 GCC Countries Viral and Non-Viral Vector Manufacturing Market Forecast

10.6 Global Viral and Non-Viral Vector Manufacturing Forecast by Type (2023-2028)

10.7 Global Viral and Non-Viral Vector Manufacturing Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Boehringer Ingelheim

11.1.1 Boehringer Ingelheim Company Information

11.1.2 Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Product Offered

11.1.3 Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Boehringer Ingelheim Main Business Overview

11.1.5 Boehringer Ingelheim Latest Developments

11.2 Catalent, Inc.

11.2.1 Catalent, Inc. Company Information

11.2.2 Catalent, Inc. Viral and Non-Viral Vector Manufacturing Product Offered

11.2.3 Catalent, Inc. Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Catalent, Inc. Main Business Overview

11.2.5 Catalent, Inc. Latest Developments

11.3 FUJIFILM Holdings Corporation

11.3.1 FUJIFILM Holdings Corporation Company Information

11.3.2 FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Product Offered

11.3.3 FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 FUJIFILM Holdings Corporation Main Business Overview

11.3.5 FUJIFILM Holdings Corporation Latest Developments

11.4 Danaher Corporation

11.4.1 Danaher Corporation Company Information

11.4.2 Danaher Corporation Viral and Non-Viral Vector Manufacturing Product Offered

11.4.3 Danaher Corporation Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Danaher Corporation Main Business Overview

11.4.5 Danaher Corporation Latest Developments

11.5 Genscript Biotech Corporation

11.5.1 Genscript Biotech Corporation Company Information

11.5.2 Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Product Offered

11.5.3 Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Genscript Biotech Corporation Main Business Overview

11.5.5 Genscript Biotech Corporation Latest Developments

11.6 Lonza Group AG

11.6.1 Lonza Group AG Company Information

11.6.2 Lonza Group AG Viral and Non-Viral Vector Manufacturing Product Offered

11.6.3 Lonza Group AG Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Lonza Group AG Main Business Overview

11.6.5 Lonza Group AG Latest Developments

11.7 Merck KGaA Inc.

11.7.1 Merck KGaA Inc. Company Information

11.7.2 Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Product Offered

11.7.3 Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Merck KGaA Inc. Main Business Overview

11.7.5 Merck KGaA Inc. Latest Developments

11.8 Oxford Biomedica Plc

11.8.1 Oxford Biomedica Plc Company Information

11.8.2 Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Product Offered

11.8.3 Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Oxford Biomedica Plc Main Business Overview

11.8.5 Oxford Biomedica Plc Latest Developments

11.9 Sartorius AG

11.9.1 Sartorius AG Company Information

11.9.2 Sartorius AG Viral and Non-Viral Vector Manufacturing Product Offered

11.9.3 Sartorius AG Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Sartorius AG Main Business Overview

11.9.5 Sartorius AG Latest Developments

11.10 Takara Bio Inc.

11.10.1 Takara Bio Inc. Company Information

11.10.2 Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Product Offered

11.10.3 Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Takara Bio Inc. Main Business Overview

11.10.5 Takara Bio Inc. Latest Developments

11.11 Thermo Fisher Scientific Inc.

11.11.1 Thermo Fisher Scientific Inc. Company Information

11.11.2 Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Product Offered

11.11.3 Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Thermo Fisher Scientific Inc. Main Business Overview

11.11.5 Thermo Fisher Scientific Inc. Latest Developments

11.12 Wuxi AppTec

11.12.1 Wuxi AppTec Company Information

11.12.2 Wuxi AppTec Viral and Non-Viral Vector Manufacturing Product Offered

11.12.3 Wuxi AppTec Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Wuxi AppTec Main Business Overview

11.12.5 Wuxi AppTec Latest Developments

11.13 Acuitas Therapeutics

11.13.1 Acuitas Therapeutics Company Information

11.13.2 Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Product Offered

11.13.3 Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Acuitas Therapeutics Main Business Overview

11.13.5 Acuitas Therapeutics Latest Developments

11.14 Evonik Industries AG

11.14.1 Evonik Industries AG Company Information

11.14.2 Evonik Industries AG Viral and Non-Viral Vector Manufacturing Product Offered

11.14.3 Evonik Industries AG Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Evonik Industries AG Main Business Overview

11.14.5 Evonik Industries AG Latest Developments

11.15 Exelead, Inc.

11.15.1 Exelead, Inc. Company Information

11.15.2 Exelead, Inc. Viral and Non-Viral Vector Manufacturing Product Offered

11.15.3 Exelead, Inc. Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Exelead, Inc. Main Business Overview

11.15.5 Exelead, Inc. Latest Developments

11.16 Entos Pharmaceuticals

11.16.1 Entos Pharmaceuticals Company Information

11.16.2 Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Product Offered

11.16.3 Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Entos Pharmaceuticals Main Business Overview

11.16.5 Entos Pharmaceuticals Latest Developments

11.17 Genevant Sciences GmbH

11.17.1 Genevant Sciences GmbH Company Information

11.17.2 Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Product Offered

11.17.3 Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Genevant Sciences GmbH Main Business Overview

11.17.5 Genevant Sciences GmbH Latest Developments

11.18 T&T Scientific Corporation

11.18.1 T&T Scientific Corporation Company Information

11.18.2 T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Product Offered

11.18.3 T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 T&T Scientific Corporation Main Business Overview

11.18.5 T&T Scientific Corporation Latest Developments

11.19 Moderna, Inc.

11.19.1 Moderna, Inc. Company Information

11.19.2 Moderna, Inc. Viral and Non-Viral Vector Manufacturing Product Offered

11.19.3 Moderna, Inc. Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 Moderna, Inc. Main Business Overview

11.19.5 Moderna, Inc. Latest Developments

11.20 CureVac N.V.

11.20.1 CureVac N.V. Company Information

11.20.2 CureVac N.V. Viral and Non-Viral Vector Manufacturing Product Offered

11.20.3 CureVac N.V. Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)

11.20.4 CureVac N.V. Main Business Overview

11.20.5 CureVac N.V. Latest Developments

12 Research Findings and Conclusion

Table 1. Viral and Non-Viral Vector Manufacturing Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Viral Vectors

Table 3. Major Players of Non-Viral Vectors

Table 4. Viral and Non-Viral Vector Manufacturing Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Viral and Non-Viral Vector Manufacturing Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Viral and Non-Viral Vector Manufacturing Market Size Market Share by Type (2017-2022)

Table 7. Viral and Non-Viral Vector Manufacturing Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Viral and Non-Viral Vector Manufacturing Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Viral and Non-Viral Vector Manufacturing Market Size Market Share by Application (2017-2022)

Table 10. Global Viral and Non-Viral Vector Manufacturing Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Viral and Non-Viral Vector Manufacturing Revenue Market Share by Player (2020-2022)

Table 12. Viral and Non-Viral Vector Manufacturing Key Players Head office and Products Offered

Table 13. Viral and Non-Viral Vector Manufacturing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Viral and Non-Viral Vector Manufacturing Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Viral and Non-Viral Vector Manufacturing Market Size Market Share by Regions (2017-2022)

Table 18. Americas Viral and Non-Viral Vector Manufacturing Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Viral and Non-Viral Vector Manufacturing Market Size Market Share by Country (2017-2022)

Table 20. Americas Viral and Non-Viral Vector Manufacturing Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Viral and Non-Viral Vector Manufacturing Market Size Market Share by Type (2017-2022)

Table 22. Americas Viral and Non-Viral Vector Manufacturing Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Viral and Non-Viral Vector Manufacturing Market Size Market Share by Application (2017-2022)

Table 24. APAC Viral and Non-Viral Vector Manufacturing Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Viral and Non-Viral Vector Manufacturing Market Size Market Share by Region (2017-2022)

Table 26. APAC Viral and Non-Viral Vector Manufacturing Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Viral and Non-Viral Vector Manufacturing Market Size Market Share by Type (2017-2022)

Table 28. APAC Viral and Non-Viral Vector Manufacturing Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Viral and Non-Viral Vector Manufacturing Market Size Market Share by Application (2017-2022)

Table 30. Europe Viral and Non-Viral Vector Manufacturing Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Viral and Non-Viral Vector Manufacturing Market Size Market Share by Country (2017-2022)

Table 32. Europe Viral and Non-Viral Vector Manufacturing Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Viral and Non-Viral Vector Manufacturing Market Size Market Share by Type (2017-2022)

Table 34. Europe Viral and Non-Viral Vector Manufacturing Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Viral and Non-Viral Vector Manufacturing Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Viral and Non-Viral Vector Manufacturing

Table 43. Key Market Challenges & Risks of Viral and Non-Viral Vector Manufacturing

Table 44. Key Industry Trends of Viral and Non-Viral Vector Manufacturing

Table 45. Global Viral and Non-Viral Vector Manufacturing Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Viral and Non-Viral Vector Manufacturing Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Viral and Non-Viral Vector Manufacturing Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Viral and Non-Viral Vector Manufacturing Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Viral and Non-Viral Vector Manufacturing Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Viral and Non-Viral Vector Manufacturing Market Size Market Share Forecast by Application (2023-2028)

Table 51. Boehringer Ingelheim Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors

Table 52. Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Product Offered

Table 53. Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Boehringer Ingelheim Main Business

Table 55. Boehringer Ingelheim Latest Developments

Table 56. Catalent, Inc. Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors

Table 57. Catalent, Inc. Viral and Non-Viral Vector Manufacturing Product Offered

Table 58. Catalent, Inc. Main Business

Table 59. Catalent, Inc. Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Catalent, Inc. Latest Developments

Table 61. FUJIFILM Holdings Corporation Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors

Table 62. FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Product Offered

Table 63. FUJIFILM Holdings Corporation Main Business

Table 64. FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. FUJIFILM Holdings Corporation Latest Developments

Table 66. Danaher Corporation Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors

Table 67. Danaher Corporation Viral and Non-Viral Vector Manufacturing Product Offered

Table 68. Danaher Corporation Main Business

Table 69. Danaher Corporation Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Danaher Corporation Latest Developments

Table 71. Genscript Biotech Corporation Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors

Table 72. Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Product Offered

Table 73. Genscript Biotech Corporation Main Business

Table 74. Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Genscript Biotech Corporation Latest Developments

Table 76. Lonza Group AG Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors

Table 77. Lonza Group AG Viral and Non-Viral Vector Manufacturing Product Offered

Table 78. Lonza Group AG Main Business

Table 79. Lonza Group AG Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Lonza Group AG Latest Developments

Table 81. Merck KGaA Inc. Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors

Table 82. Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Product Offered

Table 83. Merck KGaA Inc. Main Business

Table 84. Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Merck KGaA Inc. Latest Developments

Table 86. Oxford Biomedica Plc Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors

Table 87. Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Product Offered

Table 88. Oxford Biomedica Plc Main Business

Table 89. Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Oxford Biomedica Plc Latest Developments

Table 91. Sartorius AG Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors

Table 92. Sartorius AG Viral and Non-Viral Vector Manufacturing Product Offered

Table 93. Sartorius AG Main Business

Table 94. Sartorius AG Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Sartorius AG Latest Developments

Table 96. Takara Bio Inc. Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors

Table 97. Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Product Offered

Table 98. Takara Bio Inc. Main Business

Table 99. Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Takara Bio Inc. Latest Developments

Table 101. Thermo Fisher Scientific Inc. Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors

Table 102. Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Product Offered

Table 103. Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Thermo Fisher Scientific Inc. Main Business

Table 105. Thermo Fisher Scientific Inc. Latest Developments

Table 106. Wuxi AppTec Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors

Table 107. Wuxi AppTec Viral and Non-Viral Vector Manufacturing Product Offered

Table 108. Wuxi AppTec Main Business

Table 109. Wuxi AppTec Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. Wuxi AppTec Latest Developments

Table 111. Acuitas Therapeutics Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors

Table 112. Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Product Offered

Table 113. Acuitas Therapeutics Main Business

Table 114. Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. Acuitas Therapeutics Latest Developments

Table 116. Evonik Industries AG Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors

Table 117. Evonik Industries AG Viral and Non-Viral Vector Manufacturing Product Offered

Table 118. Evonik Industries AG Main Business

Table 119. Evonik Industries AG Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. Evonik Industries AG Latest Developments

Table 121. Exelead, Inc. Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors

Table 122. Exelead, Inc. Viral and Non-Viral Vector Manufacturing Product Offered

Table 123. Exelead, Inc. Main Business

Table 124. Exelead, Inc. Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 125. Exelead, Inc. Latest Developments

Table 126. Entos Pharmaceuticals Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors

Table 127. Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Product Offered

Table 128. Entos Pharmaceuticals Main Business

Table 129. Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 130. Entos Pharmaceuticals Latest Developments

Table 131. Genevant Sciences GmbH Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors

Table 132. Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Product Offered

Table 133. Genevant Sciences GmbH Main Business

Table 134. Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 135. Genevant Sciences GmbH Latest Developments

Table 136. T&T Scientific Corporation Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors

Table 137. T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Product Offered

Table 138. T&T Scientific Corporation Main Business

Table 139. T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 140. T&T Scientific Corporation Latest Developments

Table 141. Moderna, Inc. Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors

Table 142. Moderna, Inc. Viral and Non-Viral Vector Manufacturing Product Offered

Table 143. Moderna, Inc. Main Business

Table 144. Moderna, Inc. Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 145. Moderna, Inc. Latest Developments

Table 146. CureVac N.V. Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors

Table 147. CureVac N.V. Viral and Non-Viral Vector Manufacturing Product Offered

Table 148. CureVac N.V. Main Business

Table 149. CureVac N.V. Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 150. CureVac N.V. Latest Developments

List of Figures

Figure 1. Viral and Non-Viral Vector Manufacturing Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Viral and Non-Viral Vector Manufacturing Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Viral and Non-Viral Vector Manufacturing Market Size Market Share by Type in 2021

Figure 7. Viral and Non-Viral Vector Manufacturing in Gene Therapy

Figure 8. Global Viral and Non-Viral Vector Manufacturing Market: Gene Therapy (2017-2022) & ($ Millions)

Figure 9. Viral and Non-Viral Vector Manufacturing in Vaccinology

Figure 10. Global Viral and Non-Viral Vector Manufacturing Market: Vaccinology (2017-2022) & ($ Millions)

Figure 11. Viral and Non-Viral Vector Manufacturing in Cell Therapy

Figure 12. Global Viral and Non-Viral Vector Manufacturing Market: Cell Therapy (2017-2022) & ($ Millions)

Figure 13. Viral and Non-Viral Vector Manufacturing in Others

Figure 14. Global Viral and Non-Viral Vector Manufacturing Market: Others (2017-2022) & ($ Millions)

Figure 15. Global Viral and Non-Viral Vector Manufacturing Market Size Market Share by Application in 2021

Figure 16. Global Viral and Non-Viral Vector Manufacturing Revenue Market Share by Player in 2021

Figure 17. Global Viral and Non-Viral Vector Manufacturing Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Viral and Non-Viral Vector Manufacturing Market Size 2017-2022 ($ Millions)

Figure 19. APAC Viral and Non-Viral Vector Manufacturing Market Size 2017-2022 ($ Millions)

Figure 20. Europe Viral and Non-Viral Vector Manufacturing Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size 2017-2022 ($ Millions)

Figure 22. Americas Viral and Non-Viral Vector Manufacturing Value Market Share by Country in 2021

Figure 23. Americas Viral and Non-Viral Vector Manufacturing Consumption Market Share by Type in 2021

Figure 24. Americas Viral and Non-Viral Vector Manufacturing Market Size Market Share by Application in 2021

Figure 25. United States Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Viral and Non-Viral Vector Manufacturing Market Size Market Share by Region in 2021

Figure 30. APAC Viral and Non-Viral Vector Manufacturing Market Size Market Share by Application in 2021

Figure 31. China Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Viral and Non-Viral Vector Manufacturing Market Size Market Share by Country in 2021

Figure 38. Europe Viral and Non-Viral Vector Manufacturing Market Size Market Share by Type in 2021

Figure 39. Europe Viral and Non-Viral Vector Manufacturing Market Size Market Share by Application in 2021

Figure 40. Germany Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size Market Share by Application in 2021

Figure 48. Egypt Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 54. APAC Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 55. Europe Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 57. United States Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 58. Canada Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 61. China Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 62. Japan Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 63. Korea Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 65. India Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 66. Australia Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 67. Germany Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 68. France Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 69. UK Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 70. Italy Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 71. Russia Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 72. Spain Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 75. Israel Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)